# Reducing Elevated Heart Rate in Patients With Severe Sepsis by Ivabradine

> **NCT03367026** · NA · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Sepsis, Severe

## Interventions

- **DRUG:** Ivabradine Oral Product

## Key facts

- **NCT ID:** NCT03367026
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-06-30
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2017-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03367026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03367026, "Reducing Elevated Heart Rate in Patients With Severe Sepsis by Ivabradine". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT03367026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*